Browse > Article
http://dx.doi.org/10.5487/TR.2007.23.4.289

Effects of Lipopolysaccharide on Pharmacokinetics of Drugs  

Yang, Kyung-Hee (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lee, Myung-Gull (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Publication Information
Toxicological Research / v.23, no.4, 2007 , pp. 289-299 More about this Journal
Abstract
Lipopolysaccharide (LPS) endotoxin is an active component in the outer membrane of Gram-negative bacteria. LPS is usually used as an inflammatory animal model. During the inflammation, diarrhea and changes in plasma proteins, in hepatic and/or intestinal microsomal cytochrome P450 (CYP) isozymes, and in the renal and/or biliary excretion of drugs have been reported. Thus, in rats pretreated with lipopolysaccharide endotoxin isolated from Klebsiella pneumoniae (KPLPS rats), the absorption, distribution, metabolism, and excretion of drugs could be expected to be altered. Interestingly time-dependent effects on the hepatic CYP isozymes have been reported in KPLPS rats. Thus, in KPLPS rats, the pharmacokinetics of drugs which are mainly metabolized via CYP isozymes could be expected to be time-dependent. In this review, an attempt to explain changes in pharmacokinetics of drug reported in the literature was made in terms of CYP isozyme changes or urinary and/or biliary excretion changes in KPLPS rats.
Keywords
Pharmacokinetics; KPLPS rats; Hepatic CYP isozymes; Biliary and/or urinary excretion; Rats;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bertini, R., Bianchi, M., Erroi, A., Villa, P. and Ghezzi, P. (1989). Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron. J. Leukoc. Biol., 46, 254-262   DOI
2 Cassatella, M.A., Meda, L., Bonora, S., Ceska, M. and Constantin, G. (1993). Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med., 78, 2207-2211
3 Choi, Y.H. and Lee, M.G. (2006). Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br. J. Pharmacol., 149, 424-430   DOI   ScienceOn
4 Choi, Y.H., Kim, S.G. and Lee, M.G. (2006). Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects. J. Pharm. Sci., 95, 2543- 2552   DOI   ScienceOn
5 Churchill, P.C., Bidani, A.K. and Schwartz, M.M. (1987). Renal effects of endotoxin in the male rat. Am. J. Physiol., 253, F244-F250
6 Hasegawa, T., Nadia, M., Wang, L., Haghgoo, S., Nabeshima, T. and Kato, N. (1994b). Influence of endotoxin and lipid A on the renal handling and accumulation of gentamicin in rats. Biol. Pharm. Bull., 17, 1651-1655   DOI   ScienceOn
7 Hewett, J.A. and Roth, R.A. (1993). Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev., 45, 382-411
8 Hinshaw, L.B., Brandley, G.M. and Carlson, C.H. (1959), Effect of endotoxin on renal function in the dog. Am. J. Physiol., 196, 1127-1131
9 Kikeri, D., Pennell, J.P., Hwang, K.H., Jacob, A.I., Richman, A.V. and Bourgoignie, J.J. (1986). Endotoxemic acute renal failure in awake rats. Am. J. Physiol., 250, F1098- F1106
10 Kim, Y.C., Shim, H.J., Lee, J.H., Kim, S.H., Kwon, J.W., Kim, W.B. and Lee, M.G. (2005a). Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA- 8159, a new erectogenic, in rats. Biopharm. Drug Dispos., 26, 233-241   DOI   ScienceOn
11 Kunihara, M., Nagai, J., Murakami, T. and Takano, M. (1998). Renal excretion of rhodamine 123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. J. Pharm. Pharmacol., 50, 1161-1165   DOI
12 Leclercq, V., Desager, J.P., Horsmans, Y., van Nieuwenhuyze, Y. and Harvengt, C. (1989). Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine. Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 593-598
13 Lee, M.G. and Chiou, W.L. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J. Pharmacokinet. Biopharm., 11, 623-640   DOI
14 Nadai, M., Sekido, T., Matsuda, I., Li, W., Kitaichi, K., Itoh, A., Nabeshima, T. and Hasegawa, T. (1998). Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats. J. Pharm. Pharmacol., 50, 871-879   DOI
15 Wang, L., Hasegawa, T., Nadai, M., Muraoka, I., Nabeshima, T. and Kato, N. (1993). The effect of lipopolysaccharide on the disposition of xanthines in rats. J. Pharm. Pharmacol., 45, 34-38   DOI
16 Rietschel, E.T., Kirikae, T., Schade, F.U., Ulmer, A.J., Holst, O., Brade, H., Schmidt, G., Mamat, U., Grimmecke, H.D. and Kusumoto, S. (1993). The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology, 187, 169-190   DOI
17 Sewer, M.B. and Morgan, E.T. (1998). Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production. J. Pharmacol. Exp. Ther., 287, 352-358
18 Sewer, M.B., Koop, D.R. and Morgan, E.T. (1996). Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab. Dispos., 24, 401-407
19 Wright, K. and Morgan, E.T. (1990). Transcriptional and posttranscriptional suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett., 271, 59-61   DOI   ScienceOn
20 Crawford, E.K., Ensor, J.E., Kalvakolanu, I. and Hasday, J.D. (1993). The role of 3' poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J. Biol. Chem., 272, 21120-21127   DOI   ScienceOn
21 Evans, T.J., Strivens, E., Carpenter, A. and Cohen, J. (1993). Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection. J. Immunol., 150, 5033-5040
22 Roe, A.L., Warren, G., Hou, G., Howard, G., Shedlofsky, S.I. and Blouin, R.A. (1998). The effect of high dose endotoxin on CYP3A2 expression in the rat. Pharm. Res., 15, 1603-1608   DOI   ScienceOn
23 Kim, Y.C., Yoo, M. and Lee, M.G. (2005b). DA-8159, Erectogenic. Drugs Future, 30, 678,682   DOI
24 Morgan, E.T. (1989). Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol., 36, 699-707
25 Ogawa, K., Takagi, K. and Satake, T. (1989). Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle. Br. J. Pharmacol., 97, 542-546   DOI   ScienceOn
26 Shi, J., Montay, G. and Bhargava, V.O. (2005). Clinical pharmacokinetics of telithromycin, the first ketolide antibacteantibacterial. Clin. Pharmacokinet., 44, 915-934   DOI   ScienceOn
27 Gorodischer, F., Krasner, J., McDevitt, J.J., Nolan, J.P. and Yaffe, S.J. (1976). Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem. Pharmacol., 25, 351-353   DOI   ScienceOn
28 Lee, J.H. and Lee, M.G. (2007b). Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability. J. Pharm. Pharm. Sci., 10, 37-50
29 Minors, J.O. and McKinnon, R.A. (2000). CYP1A. In Metabolic Drug Interactions. (Levy, R.H., Thummel, K.E., Trager, W.F., Hansten, P.D. and Eichelbaum, M. Eds.) A Wolters Kluwer Company, Philadelphia, PA, USA: Lippincott Williams & Wilkins, pp. 61-74
30 Morgan, E.T. (1993). Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis. Biochem. Pharmacol., 45, 415-419   DOI   ScienceOn
31 Westphal, O., Jann, K. and Himmelspach, K. (1983). Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog. Allergy, 33, 9- 39
32 Hasegawa, T., Nadai, M., Wang, L., Takayama, Y., Kato, K., Nabeshima, T. and Kato, K. (1994a). Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysccharide in rats. Drug Metab. Dispos., 22, 8-13
33 Ji, H.Y., Lee, H.W. and Kim, H.H. (2004). Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic. Xenobiotica, 34, 973-992   DOI   ScienceOn
34 Miyamoto, K., Koshiura, R., Hasegawa, T. and Kato, N. (1984). Antitumor activity of Klebsiella 03 lipopolysaccharide in mice. Jpn. J. Pharmacol., 36, 51-57   DOI
35 Kido, N., Ohta, M., Ito, H., Naito, S., Nagase, F., Nakashima, I. and Kato, N. (1985). Potent adjuvant action of lipopolysaccharides possessing the O-specific polysaccharide moieties consisting of mannans in antibody response against protein antigen. Cell. Immunol., 91, 52-59   DOI
36 Matsunaga, Y., Miyazaki, H., Oh-e, Y., Nambu, K., Furkawa, H., Yoshida, K. and Hashimoto, M. (1991). Disposition and metabolism of TEX>$^{14}C$-sparfloxacn in the rat. Arzneim-Forsch/ Drug Res., 41, 747-759
37 Mitruka, B.M. and Rawnsley, H.M. (1981). Clinical Biomedical and Hematological Reference Values in Normal Experimental Animals and Normal Humans, 2nd ed. Masson Publishing USA Inc., New York. NY
38 Nadai, M., Zhao, Y.L., Wang, L., Nishio, Y., Takagi, K., Kitaichi, K., Takagi, K., Yshizumi, H. and Hasegawa, T. (2001). Endotoxin impairs biliary transport of sparfloxacin and its gucuronide in rats. Eur. J. Pharm., 432, 99-105   DOI   ScienceOn
39 Yang, K.H., Lee, J.H. and Lee, M.G. (2008). Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. J. Pharm. Pharmcol., (in press)
40 Cheng, PY., Wang, M. and Morgan, E.T. (2003). Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J. Pharmacol. Exp. Ther., 307, 1205-1212   DOI   ScienceOn
41 Morgan, E.T., Li-Masters, T. and Cheng, P.Y. (2002). Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology, 181-182, 207-210
42 Sachdeva, K., Yan, B. and Chichester, C.O. (2003). Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock, 19, 469-474   DOI   ScienceOn
43 Williams, J.F., Lowitt, S. and Szentivanyi, A. (1979). Effect of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. Biochem. Pharmacol., 8, 2935-2940
44 Lewis, D.F.V. (1996). Chapter 4. P450. Substrate specificity and metabolism. In Cytochromes P450, Structure, Function and Mechanism. (Lewis, D.F.V. Ed.) 2nd edn. Bristol, PA, USA: Taylor & Francis, p. 123
45 Nadai, M., Hasagawa, T., Wang, L., Haghgoo, S., Nabeshima, T. and Kato, N. (1995). Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats. Biol. Pharm. Bull., 18, 1089-1093   DOI
46 Choi, Y.H., Lee, I. and Lee, M.G. (2007b). Effects of water deprivation on the pharmacokinetics of metformin in rats. Biopharm. Drug Dispos., 28, 373-383   DOI   ScienceOn
47 Ferrari, L., Peng, N., Halpert, J.R. and Morgan, E.T. (2001). Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes. Mol. Pharmacol., 60, 209-216   DOI
48 Akiyama, H., Abe, Y., Kusumoto, N. and Odomi, M. (1995). Pharmacokinetics of grepafloxacn (II): absorption, distribution and excretion after oral administratio of [$^{14}C$]-grepafloxacin in rats. Chemotherapy, 43, 107-124
49 Kushner, I. (1982). The phenomenon of the acute phase response. Ann. N. Y. Acad. Sci., 389, 39-48   DOI
50 Davies, B. and Morris, T. (1993). Physiological parameters in laboratory animals and humans. Pharm. Res., 10, 1093- 1095   DOI
51 Monshouwer, M., McLellan, R.A., Delaporte, E., Witkamp, R.F., van Miert, A.S.J.P.A.M. and Renton, K.W. (1996). Differential effect of pentoxifylline on lipopolysaccharideinduced downregulation of cytochrome P450. Biochem. Pharmacol., 52, 1195-1200   DOI   ScienceOn
52 Szakacs, T., Veres, Z. and Vereczkey, L. (2001). Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes. Pol. J. Pharmacol., 53, 11-19
53 Yang, K.H., Jung, Y.S., Lee, D.Y., Lee, J.H., Kim, Y.C. and Lee, M.G. (2007). Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats; return of the parameters in 96-h KPLPS rats to the control levels. Proceedings of the Convention of the Pharmaceutical Society of Korea, Hotel- Seoul Kyoyuk Munhwa Hoekwan, Nov. 7-8, 2007, Abstract p. 419
54 Haghgoo, S., Hasegawa, T., Nadai, M., Wang, L., Nabeshima, T. and Kato, N. (1995). Effect of a bacterial lipopolysaccharide on biliary excretion of a $\beta$-lactam antibiotic, cefoperazone, in rats. Antimicrob. Agents Chemother., 39, 2258-2261   DOI   ScienceOn
55 Lee, J.H., Cho, Y.K. and Lee, M.G. (2007a). Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on telithromycin pharmacokinetics in rats; return of the parameters in 96-hour KPLPS to the control levels. Proceedings of the Convention of the Pharmaceutical Society of Korea, Hotel-Seoul Kyoyuk Munhwa Hoekwan, Nov. 7-8, 2007, Abstract p. 414
56 Miyamoto, K., Takagi, K., Sakai, R., Wakusawa, S., koshiura, R., Nadai, M., Apichartpichean, R. and Hasegawa, T. (1989). Correlation between hydrophobicity of N-alkylxanthine derivatives and their biological activities on guineapig isolated tracheal smooth muscle. J. Pharm. Pharmacol., 41, 844-847   DOI
57 Ueyama, J., Nadai, M., Kanazawa, H., Iwase, M., Nakayama, H., Hashimoto, K., Yokoi, T., Baba, K., Takagi, K., Takagi, K. and Hasegawa, T. (2005). Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. Eur. J. Pharmacol., 510, 127-134   DOI   ScienceOn
58 Levy, R.H., Thummel, K.E., Trager, W.F., Hansten, P.D. and Eichelbaum, M. Metabolic Drug Interactions. Philadelphia, BA, USA: Lippincott Williams & Wilkins, a Wolters Kluwer Company, 2000
59 Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato, N. (1993a). The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS). Drug Metab. Dispos., 21, 611-616
60 Wilkinson, G.R. and Shand, D.G. (1975). A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther., 18, 377-390   DOI
61 Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato, N. (1993c). Alterations in pharmacokinetics and protein binding behavior of cefazoiln in endotoxemic rats. Antimicrob. Agents Chemother., 37, 1781-1785   DOI   ScienceOn
62 Lee, J.H., Kim, Y.C., Kwon, J.W., Kim, W.B. and Lee, M.G. (2007b). Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic in rats. Res. Commun. Mol. Pathol. Pharmacol., (in press)
63 Bae, S.K., Lee, S.J., Kwon, J.W., Kim, W.B., Lee, I. and Lee, M.G. (2004). Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidone, in rats. J. Pharm. Sci., 93, 2364-2373   DOI   ScienceOn
64 Choi, Y.H., Lee, I. and Lee, M.G. (2007a). Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats. Int. J. Pharm., 337, 194-201   DOI   ScienceOn
65 Hasegawa, T., Ohta, M., Kido, N., Kato, N., Miyamoto, K. and Koshiura, R. (1985). Comparative studies on antitumor activity of Klebsiella O3 lipopolysaccharide and its polysaccharide fraction in mice. Jpn. J. Pharmacol., 38, 355-360   DOI
66 Llewelyn, M. and Cohen, J. (2001). New insights into the pathogenesis and therapy of sepsis and septic shock. Curr. Clin. Top. Infect. Dis., 21, 148-171
67 Ohta, M., Nakashima, I. and Kato, N. (1982). Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities. Immunobiology., 163, 460-469   DOI
68 Ortiz de Montellano, P.R. (2005). Cytochrome P450. Structure, Mechanism, and Biochemistry. 3rd edn. New York, USA: Kluwer Academic/Plenum Publishers
69 Ando, K., Nishio, Y., Ito, K., Nakao, A., Wang, L., Zhao, Y.L., Kitaichi, K., Takagi, K. and Hasegawa, T. (2001). Effect of endotoxin on P-glycoproein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob. Agents Chemother., 45, 3462-3467   DOI   ScienceOn
70 Kato, N., Ohta, M., Kido, N., Naito, S., Nakashima, I., Nagase, F. and Yokochi, T. (1985). Strong adjuvanticity of bacterial lipopolysaccharides possessing the homopolysaccharides consisting of mannose as the O-specific polysaccharide chains. Med. Microbiol. Immunol., 174, 1-14
71 Nadai, M., Kato, M., Yasui, K., Kimura, M., Zhao, Y.L., Ueyama, J., Tsumekawa, Y., Yoshizumi, H. and Kasegawa, Y. (2007). Lack of effect of acyclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats. Biol. Pharm. Bull., 30, 562-568   DOI   ScienceOn
72 Remick, D., Manohar, P., Bolgos, G., Rodriguez, J., Moldawer, L. and Wollenberg, G. (1995). Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock, 4, 89-95   DOI   ScienceOn
73 Scheen, A.J. (1996). Clinical pharmacokinetics of metformin. Clin. Pharmacokinet., 30, 359-371   DOI   ScienceOn
74 Engel, G., Hofmann, U., Heidemann, H., Cosme, J. and Eichelbaum, M. (1996). Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin. Pharmacol. Ther., 59, 613-623   DOI
75 Lee, J.H. and Lee, M.G. (2007a). Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin. Biopharm. Drug Dispos., 28, 157-166   DOI   ScienceOn
76 Cavanagh, D., Rao, P.S., Sutton, D.M., Bhagat, B.D. and Bachmann, F. (1970). Pathophysiology of endotoxin shock in the primate. Am. J. Obstet. Gynecol., 108, 705-722   DOI
77 Bae, S.K., Kim, E.J., Kwon, J.W., Kim, W.B., Lee, I. and Lee, M.G. (2005). Excretion and metabolism of DA-7867, a new oxazolidinone, in rats. Biopharm. Drug Dispos., 26, 67-75   DOI   ScienceOn
78 Kalitsky-Szirtes, J., Shayeganpour, A., Brocks, D.R. and Piquette-Miller, M. (2004). Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab. Dispos., 32, 20-27   DOI   ScienceOn
79 Liu, P., McGuire, G.M., Fisher, M.A., Farhood, A., Smith, C.W. and Jaeschke, H. (1995). Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock, 3, 56-62   DOI   ScienceOn
80 Nadai, M., Hasegawa, T., Kato, K., Wang, L., Nabeshima, T. and Kato. N. (1993b). Influence of a bacterial lipopolysaccharide on the pharmacokinetics of pharmacokinetics of tobramycin in rats. J. Pharm. Pharmacol., 45, 971-974   DOI
81 Shim, H.J., Kim, Y.C., Park, K.J., Kim, D.S., Kwon, J.W., Kim, W.B. and Lee, M.G. (2003). Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. J. Pharm. Sci., 11, 2185-2195
82 Freudenberg, M.A., Keppler, D. and Galanos, C. (1986). Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun., 51, 891-895
83 Gilbert, R.P. (1960). Mechanisms of the hemodynamic effects of endotoxin. Physiol. Rev., 40, 245-279   DOI
84 Nadai, M., Hasegawa, T., Wang, L., Haghgoo, S., Okasaka, T., Mabeshima, T. and Kato, N. (1996). Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice. J. Pharm. Pharmacol., 48, 744-748   DOI